These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16244212

  • 1. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M, Vogel M, Wright C, Smith J, Haworth SG.
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA, Grimminger F.
    Dtsch Med Wochenschr; 2006 Dec 08; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [Abstract] [Full Text] [Related]

  • 3. Sildenafil in pulmonary hypertension.
    Nanivadekar A.
    Indian Heart J; 2003 Dec 08; 55(3):285; author reply 285. PubMed ID: 14560947
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sildenafil in primary pulmonary hypertension.
    Prasad S, Wilkinson J, Gatzoulis MA.
    N Engl J Med; 2000 Nov 02; 343(18):1342. PubMed ID: 11183578
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A, Mathew V, Sahu A, Lunia B.
    Indian Heart J; 2003 Nov 02; 55(1):55-9. PubMed ID: 12760589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.
    Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, Kneussl M, Grimminger F.
    J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):68S-72S. PubMed ID: 15194181
    [Abstract] [Full Text] [Related]

  • 13. Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption.
    Lammers AE, Haworth SG, Pierce CM.
    Cardiol Young; 2006 Feb 16; 16(1):84-6. PubMed ID: 16454884
    [Abstract] [Full Text] [Related]

  • 14. Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.
    Ann Intern Med; 2004 Aug 03; 141(3):I12. PubMed ID: 15289233
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G, Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.
    N Engl J Med; 2005 Nov 17; 353(20):2148-57. PubMed ID: 16291984
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
    Steiner MK, Preston IR, Klinger JR, Hill NS.
    Curr Opin Pharmacol; 2005 Jun 17; 5(3):245-50. PubMed ID: 15907910
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R.
    Am Heart J; 2006 Apr 17; 151(4):851.e1-5. PubMed ID: 16569546
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.
    Hemnes AR, Champion HC.
    Expert Rev Cardiovasc Ther; 2006 May 17; 4(3):293-300. PubMed ID: 16716091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.